Marfan syndrome, an autosomal dominant disorder of connective tissue with an estimated prevalence of 1 in 5,000 to 10,000, is caused by abnormal fibrillin-1 attributable to mutations in the FBN1 gene (2) . Manifestations involve multiple organ systems, including the aorta, heart and valves, skeleton, eye, lungs, and dura. FBN1 mutations can be identified in the vast majority of patients satisfying the revised Ghent criteria for Marfan syndrome (2) . The diagnosis of Marfan syndrome is made by use of clinical criteria, imaging, family history, and genetic testing as outlined in the revised Ghent criteria (Tables 1 and 2) (2).
Cardiovascular features of Marfan syndrome include mitral valve prolapse, mitral regurgitation, aortic root dilatation (most pronounced at the sinuses of Valsalva), and aortic dissection (2) . The descending aorta, although less commonly involved in young patients, is also at risk for aneurysm formation and dissection.
Other genetically triggered aortic aneurysm syndromes and conditions associated with aortopathy may increase the risk of aortic dissection in competitive athletes.
Loeys-Dietz syndrome is caused by mutations in TGFBR1
and TGFBR2 and is characterized by craniofacial features, arterial tortuosity, and aneurysms of the aorta and branch vessels, as well as increased risk of dissection at relatively small arterial dimensions (3) . Vascular Ehlers-Danlos syndrome, caused by mutations in COL3A1, is associated with dissection and rupture of the aorta and branch vessels, even at relatively normal arterial dimensions.
TAA or dissection may be familial and is inherited as an autosomal dominant trait with decreased penetrance and variable expression. Mutations in several genes have been recognized as causing TAA disease, including ACTA2, TGFBR1, TGFBR2, FBN1, MYH11, SMAD3, MLCK, and TGFB2. Familial TAA syndromes may be associated with cerebral aneurysms or BAV; some patients have nonvascular manifestations (4, 5) .
BAV, which affects w1% of the general population, may be associated with dilatation of the aortic root or ascending aorta (6) . BAV with or without TAA may be familial, and the specific gene loci responsible are yet to be determined. The prevalence of BAV in first-degree relatives of a person with BAV has been demonstrated to be w9% (6) . Cystic medial degeneration and abnormal aortic wall stress accompany BAV aortic disease independent of the valvular lesion (6) . BAV with aortic aneurysm is a risk factor for aortic dissection (7) . The risk of aortic dissection differs among genetically triggered aortopathies, being higher in those with Loeys-Dietz syndrome and Marfan syndrome than in BAV aortopathy.
MEASURING THE AORTIC ROOT AND

ASCENDING AORTA
The ascending aorta may be divided into 2 segments, the aortic root and the upper ascending aorta. The aortic root begins at the aortic valve, includes the sinuses of Valsalva, and extends to the sinotubular junction. The upper portion of the ascending aorta begins at the sinotubular junction and rises to join the aortic arch. The normal aortic root diameter is dependent on multiple factors, including age, sex, body size, location of the aortic measurement, particular type of imaging modality used, and accuracy of measurement ascertainment (4, 8) . In adults, aortic diameters are larger in men than in women by 1 to 3 mm, whereas studies in children have not consistently Older nomograms that predict normal and abnormal aortic dimensions are limited by such factors as failure to account for sex differences, limited age ranges of subjects studied (especially teenagers), marked jumps in "normal"
aortic diameter based on age-range strata, and the use of small sample sizes (8, 10) .
z Scores
Notably, z scores that incorporate height, weight, age, and sex are now preferred for determination of normal aortic diameter as opposed to a single aortic dimension (8) . The z score describes how many standard deviations above or below a size or age-specific population mean a given measurement lies (12) . They are especially useful for evaluation of cardiac dimensions in the young, whose normal values change during growth.
Aortic dilatation is recognized when the difference between the observed sinus of Valsalva diameter and the value predicted for age, sex, and BSA (z score) is >2.0, which corresponds to approximately the 98th percentile of the general population (8) . A z score of 3 corresponds to the 99.9th percentile. Mild, moderate, and severe aortic dilatation may be defined by z-score values of 2 to 3, 3.01 to 4.0, and >4.0, respectively (8, 13) . Reference values for ascending aortic diameter assessed by echocardiography are also available from large databases (14) . Competitive Athletes: Aortic Diseases Thus, the z score is 3.16, which is significantly abnormal for this patient.
AORTIC DIMENSIONS IN ATHLETES
Intense physical exertion is associated with hemodynamic changes that increase aortic wall tension and may increase aortic dimension (15) (16) (17) . Chronic intense weight training may influence aortic dimension (18) . Furthermore, elite athletes have slightly larger aortas at the sinuses of Valsalva than nonathletic control subjects (19) .
Although mild aortic enlargement may be a normal adaptation to intense training, large increases in aortic size are unusual in athletes and when present are more consistent with an underlying pathological aortopathy, which may be exacerbated by exercise training (19) .
TALL ATHLETES
Although increasing BSA is associated with larger aortic diameters, there is a nonlinear relationship, with a plateau, between aortic root dimensions and height (>189 cm or 74.5 inches in men; >175 cm or 69 inches in women) and BSA (>2.3 m 2 ) in very tall people (20). A small proportion of athletes will have an aortic dimension slightly greater than the diameter considered to be at the upper limits of normal (i.e., >2 standard deviations above the mean, or z score >2) (15, 16) . Therefore, it is important to avoid attributing the enlarged aorta in tall (or large) athletes solely to height, BSA, or a physiological response to exercise (19) . Mild aortic dilation in an athlete should trigger evaluation to determine whether an underlying aortopathy is present and whether the aortic size conveys an increased risk to the athlete.
We underscore that for athletes with aortic z scores above the normal range for age, sex, and BSA (i.e., z score >2 to 2. 
OUTCOME AND RISK OF AORTIC DISSECTION AND RUPTURE
There is a paucity of data examining the long-term outcome of athletes with unexplained aortic dilatation (16, 17 (3, 5, 25, 26) . Additionally, BAV aortopathy may involve aortic segments distal to the root (27) .
PRIOR RECOMMENDATIONS FOR ATHLETES
The 36th Bethesda Conference Report (2005) recommended that athletes with "unequivocal aortic root enlargement" (therein defined as >40 mm in adults, >2
standard deviations beyond the mean for BSA in children and adolescents, or a z score of >2) only participate in lowintensity competitive sports (class IA sports) (28) . Characterizing an aortic diameter of >40 mm as enlarged in males is an arbitrary but also useful definition, because very few apparently healthy young male athletes have been reported with aortic root diameters >40 mm (17, 19) .
For example, in a study of >2,000 Italian athletes, the 99th Competitive Athletes: Aortic Diseases percentile value of aortic diameter by echocardiogram was 40 mm in males and 34 mm in females (16) . In a Japanese study, only 6 of 1,562 male athletes (0.38%) had an aortic root dimension >40 mm, and 2 of these also had phenotypic features of the Marfan syndrome (29) . In an evaluation of >1000 female Italian athletes, the 99th percentile for aortic size at the sinuses of Valsalva was 34 mm, and no woman had an aortic diameter >36 mm (16, 17) .
Guidelines for participation in competitive sports have been lacking for those patients with mildly dilated aortic dimensions (i.e., z scores of 2 to 2.5, or 1 to 2 mm above the normal ranges described above) and no diagnosis of an underlying connective tissue disorder, family history of aortic disease, or pathogenic gene mutation associated with aneurysm disease (17) . 15. Athletes with BAV and a severely dilated aorta (score >3.5 to 4 or >43 mm in men or >40 mm in women)
should not participate in any competitive sports that involve the potential for bodily collision (Class III;
Level of Evidence C). 
Athletes with
